https://www.selleckchem.com/products/gdc-0994.html
The results suggest that Apt-NPs-DTX has potential in the targeted treatment of colon cancer. The results suggest that Apt-NPs-DTX has potential in the targeted treatment of colon cancer. Oxaliplatin (L-OHP) is a well-known third-generation platinum anticancer drug with severe systemic- and neuro-toxicity. The main objective of the current research was to develop a targeted long-circulating thermosensitive smart-release liposome (LCTL) system for better therapeutic efficacy and less toxicity. The reverse-phase evaporation method (REV)